Time course of the angiogenic response during normotrophic and hypertrophic scar formation in humans
Authors:
- Frank B. NiessenFNFrank B. Niessen
- Peter J. ZwiersPZPeter J. Zwiers
- Etty H. de JongEJEtty H. de Jong
- Grietje MolemaGMGrietje Molema
- 3 May 2011
- journal article
- Published by Wiley in Wound Repair and Regeneration
- Vol. 19 (3) , 292-301
Abstract
Previous research suggests that in hypertrophic scars (HSs), an excess of microvessels is present compared with normotrophic scars (NSs). The aim of our study was to quantify vascular densities in HSs and normotrophic scars and to provide an insight into the kinetics of changes in the expression of angiogenic factors in time during wound healing and HS formation. Human presternal wound healing after cardiothoracic surgery through a sternotomy incision was investigated in a standardized manner. Skin biopsies were collected at consecutive time points, i.e., during surgery and 2, 4, 6, 12, and 52 weeks postoperatively. The expression levels of angiopoietin‐1, angiopoietin‐2, Tie‐2, vascular endothelial growth factor, and urokinase‐type plasminogen activator were measured by real‐time reverse transcription‐polymerase chain reaction. Quantification of angiogenesis and cellular localization of the proteins of interest were based on immunohistochemical analysis. Microvessel densities were higher in the HSs compared with the normotrophic scars 12 weeks (p=0.017) and 52 weeks (p=0.030) postoperatively. Angiopoietin‐1 expression was lower in the hypertrophic group (pp=0.053), 12 weeks (ppp=0.008). Vascular endothelial growth factor expression was not significantly different when comparing both groups. In summary, the differential expression of angiopoietin‐1, angiopoietin‐2, and urokinase‐type plasminogen activator in time is associated with an increased vascular density in HSs compared with normotrophic scars.Keywords
This publication has 35 references indexed in Scilit:
- Angiopoietin-1, angiopoietin-2 and Tie-2 receptor expression in human dermal wound repair and scarringBritish Journal of Dermatology, 2010
- The Role of Vascular Endothelial Growth Factor in Wound HealingJournal of Surgical Research, 2009
- Why are tumour blood vessels abnormal and why is it important to know?British Journal of Cancer, 2009
- The angiogenic makeup of human hepatocellular carcinoma does not favor vascular endothelial growth factor/angiopoietin-driven sprouting neovascularizationHepatology, 2008
- VEGF receptor signalling ? in control of vascular functionNature Reviews Molecular Cell Biology, 2006
- A Multitargeted Receptor Tyrosine Kinase Inhibitor, SU6668, Does Not Affect the Healing of Cutaneous Full-Thickness Incisional Wounds in SKH-1 MiceJournal of Investigative Surgery, 2006
- Effect of recombinant adeno-associated virus vector-mediated vascular endothelial growth factor gene transfer on wound healing after burn injury*Critical Care Medicine, 2003
- Second international consensus on the methodology and criteria of evaluation of angiogenesis quantification in solid human tumoursEuropean Journal of Cancer, 2002
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- The angiogenesis inhibitor endostatin impairs blood vessel maturation during wound healingThe FASEB Journal, 2000